BioCentury
ARTICLE | Company News

Enzon, NatImmune deal

October 10, 2005 7:00 AM UTC

NatImmune granted ENZN exclusive worldwide rights, excluding Nordic countries, to recombinant human mannan-binding lectin (rhMBL) to prevent severe infections in MBL-deficient persons undergoing chem...